肝病中的骨质疏松症：发病机制与管理
Osteoporosis in liver disease: pathogenesis and management.
作者信息
Handzlik-Orlik Gabriela, Holecki Michał, Wilczyński Krzysztof, Duława Jan
机构信息
Department of Internal Medicine and Metabolic Diseases, Medical University of Silesia, ul. Ziołowa 45/47, 40-635 Katowice, Poland.
Department of Internal Medicine and Metabolic Diseases, School of Health Science, Medical University of Silesia, Katowice, Poland.
出版信息
Ther Adv Endocrinol Metab. 2016 Jun;7(3):128-35. doi: 10.1177/2042018816641351. Epub 2016 Apr 6.
Abstract
Osteoporosis affects a substantial proportion of patients with chronic liver disease. Pathologic fracture in osteoporosis significantly affects quality of life and life expectancy. By some estimates, 40% of patients with chronic liver disease may experience osteoporotic fracture. In this study we review the pathogenesis, diagnosis and treatment of specific liver disease entities and their relation to osteoporosis.
摘要
骨质疏松症影响着相当一部分慢性肝病患者。骨质疏松症中的病理性骨折会显著影响生活质量和预期寿命。据一些估计，40%的慢性肝病患者可能会发生骨质疏松性骨折。在本研究中，我们回顾了特定肝病实体的发病机制、诊断和治疗及其与骨质疏松症的关系。
相似文献
1
Osteoporosis in liver disease: pathogenesis and management.
Ther Adv Endocrinol Metab. 2016 Jun;7(3):128-35. doi: 10.1177/2042018816641351. Epub 2016 Apr 6.
2
Osteoporosis in patients with primary biliary cirrhosis.
Eur J Gastroenterol Hepatol. 2010 Dec;22(12):1397-401. doi: 10.1097/MEG.0b013e3283405939.
3
Osteoporosis across chronic liver disease.
Osteoporos Int. 2016 Jun;27(6):1967-77. doi: 10.1007/s00198-016-3512-z. Epub 2016 Feb 4.
4
Fracture risk calculation tool enhances dual-energy X-ray absorptiometry scan referral pathway in cirrhosis patients.
Eur J Gastroenterol Hepatol. 2016 Jul;28(7):757-61. doi: 10.1097/MEG.0000000000000585.
5
Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis.
Arq Gastroenterol. 2006 Jul-Sep;43(3):224-8. doi: 10.1590/s0004-28032006000300013.
6
Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis.
J Bone Miner Metab. 2017 Nov;35(6):685-693. doi: 10.1007/s00774-016-0807-2. Epub 2016 Dec 7.
7
Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease.
Gastroenterology. 1989 Jan;96(1):213-21.
8
Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.
Drugs Aging. 2007;24(7):603-14. doi: 10.2165/00002512-200724070-00007.
9
[Secondary osteoporosis. Bone disease in liver cirrhosis.].
Clin Calcium. 2018;28(12):1659-1664.
10
[Long-term risk of osteoporotic fracture in Belgium].
Rev Med Liege. 2008 Jul-Aug;63(7-8):480-7.
引用本文的文献
1
Short-Term Outcomes of Noncemented Total Knee Arthroplasty in Patients With Morbid Obesity.
J Am Acad Orthop Surg Glob Res Rev. 2025 Mar 3;9(3). doi: 10.5435/JAAOSGlobal-D-24-00299. eCollection 2025 Mar 1.
2
Accelerated aging of skeletal muscle and the immune system in patients with chronic liver disease.
Exp Mol Med. 2024 Jul;56(7):1667-1681. doi: 10.1038/s12276-024-01287-y. Epub 2024 Jul 18.
3
How Age, Sex and Transfusion Affects the Incidence of Endocrine and Bone Density Disorders in Major Thalassemic Patients.
Iran J Public Health. 2024 Feb;53(2):433-442. doi: 10.18502/ijph.v53i2.14928.
4
High C-reactive protein-to-albumin ratio levels are associated with osteoporosis in patients with primary biliary cholangitis.
Front Endocrinol (Lausanne). 2024 May 30;15:1415488. doi: 10.3389/fendo.2024.1415488. eCollection 2024.
5
Bone-organ axes: bidirectional crosstalk.
Mil Med Res. 2024 Jun 12;11(1):37. doi: 10.1186/s40779-024-00540-9.
6
From liver to hormones: The endocrine consequences of cirrhosis.
World J Gastroenterol. 2024 Mar 7;30(9):1073-1095. doi: 10.3748/wjg.v30.i9.1073.
7
Clinical Indicators of Bone Deterioration in Alcoholic Liver Cirrhosis and Chronic Alcohol Abuse: Looking beyond Bone Fracture Occurrence.
Diagnostics (Basel). 2024 Feb 28;14(5):510. doi: 10.3390/diagnostics14050510.
8
Boosting plant food polyphenol concentration by saline eustress as supplement strategies for the prevention of metabolic syndrome: an example of randomized interventional trial in the adult population.
Front Nutr. 2023 Dec 22;10:1288064. doi: 10.3389/fnut.2023.1288064. eCollection 2023.
9
Evaluation and Management of Chronic Cholestatic Liver Diseases.
Middle East J Dig Dis. 2023 Jul;15(3):148-155. doi: 10.34172/mejdd.2023.336. Epub 2023 Jul 30.
10
Metabolic bone disease heralding the diagnosis of Wilson's disease.
BMJ Case Rep. 2023 Jul 25;16(7):e252290. doi: 10.1136/bcr-2022-252290.
本文引用的文献
1
New method for point-of-care osteoporosis screening and diagnostics.
Osteoporos Int. 2016 Mar;27(3):971-977. doi: 10.1007/s00198-015-3387-4. Epub 2015 Nov 10.
2
EASL Clinical Practice Guidelines: Autoimmune hepatitis.
J Hepatol. 2015 Oct;63(4):971-1004. doi: 10.1016/j.jhep.2015.06.030. Epub 2015 Sep 1.
3
Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women.
Osteoporos Int. 2015 Mar;26(3):1045-52. doi: 10.1007/s00198-014-2947-3. Epub 2014 Nov 19.
4
Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications.
World J Gastroenterol. 2014 Jul 28;20(28):9427-38. doi: 10.3748/wjg.v20.i28.9427.
5
Osteoporosis in primary biliary cirrhosis of the liver.
Prz Gastroenterol. 2014;9(2):82-7. doi: 10.5114/pg.2014.42502. Epub 2014 May 5.
6
Association between nutritional screening via the Controlling Nutritional Status index and bone mineral density in chronic liver disease of various etiologies.
Hepatol Res. 2015 Jun;45(6):618-28. doi: 10.1111/hepr.12395. Epub 2014 Aug 19.
7
Polish guidelines for the diagnosis and management of osteoporosis: a review of 2013 update.
Pol Arch Med Wewn. 2014;124(5):255-63. doi: 10.20452/pamw.2255. Epub 2014 Mar 27.
8
Alcoholic liver disease and changes in bone mineral density.
Rev Esp Enferm Dig. 2013 Nov-Dec;105(10):609-21. doi: 10.4321/s1130-01082013001000006.
9
Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency.
Endokrynol Pol. 2013;64(4):319-27. doi: 10.5603/ep.2013.0012.
10
Extrahepatic complications of nonalcoholic fatty liver disease.
Hepatology. 2014 Mar;59(3):1174-97. doi: 10.1002/hep.26717. Epub 2014 Jan 16.
Zotero 插件